chrisvoncsefalvay/vaers-outcomes huggingface dataset:
tunnel vision; wobbly legs; dizziness (had to sit down then lie down); sore arm; Foggy; burning on injection; fatigue; some chills; nausea; This spontaneous case was reported by a consumer and describes the occurrence of TUNNEL VISION (tunnel vision) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 025B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No relevant medical history provided). Concomitant products included PARACETAMOL (TYLENOL) for an unknown indication.    On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced TUNNEL VISION (tunnel vision) (seriousness criterion medically significant), RESTLESS LEGS SYNDROME (wobbly legs), DIZZINESS (dizziness (had to sit down then lie down)), PAIN IN EXTREMITY (sore arm), FEELING ABNORMAL (Foggy), VACCINATION SITE PAIN (burning on injection), FATIGUE (fatigue), CHILLS (some chills) and NAUSEA (nausea). On 26-Mar-2021, TUNNEL VISION (tunnel vision), RESTLESS LEGS SYNDROME (wobbly legs), FEELING ABNORMAL (Foggy), CHILLS (some chills) and NAUSEA (nausea) had resolved, DIZZINESS (dizziness (had to sit down then lie down)) and VACCINATION SITE PAIN (burning on injection) outcome was unknown. At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment medication included paracetamol.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of these events, a causal relationship cannot be excluded.
This spontaneous case was reported by an other health care professional and describes the occurrence of MYALGIA (sore arm) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 003B21A and 031A21A) for COVID-19 vaccination. No Medical History information was reported. On 23-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced MYALGIA (sore arm). On 23-May-2021, MYALGIA (sore arm) had resolved. For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments. Concomitant product use was not provided by the reporter. Treatment information was not reported. Action taken with mRNA-1273 in response to the event was not applicable. This case was linked to MOD-2021-250606 (Patient Link).
Persistent right shoulder pain leading to several visits and prompting US, MRI and ortho referral due to high-grade Articular sided partial-thickness tear at the supraspinatus and infraspinatus junction involving 50% tendon thickness with signal abnormality spanning 2.2 CM in AP dimension, mild long head biceps tenosynovitis, small glenohumeral jont effusion with mild synovitis, mild subacromial/subdeltoid, and moderate subcoracoid bursal distention with a small amount of debris. minimal AC joint degenerative change, mild degenerative change in the superior labrum
The evening  I got the shot I felt my muscles starting to ache. The next morning when I woke up I was achy, but still went to work. Around 11:00 am on 1/13/21 I started to feel flushed and the chills. Took my temp and it was 100.3 F. I was achy all over and had a headache too.
Temp 99.8, 6 episodes of vomiting, brown diarrhea.
Shortly after the vaccination I developed a really bad headache for the first 2 days.  Stopped for a day and returned for another day and went away on its own. I had inside body chills, felt weak and tired and had a little sinus pressure but no fever which lasted for about 2 or 3 days.  I took aspirin to help with the discomfort and today I still have just a little nagging headache that comes and goes but all other symptoms has since subsided.  The injection site swole and developed a knot which stayed about a week and is still a little red.
Information has been received from a lab technician concerning a female patient "in her 60s" who on 23-SEP-2009 was vaccinated with a dose of PNEUMOVAX (Lot # 662841/0626Y) 0.5 ml, IM.  On 23-SEP-2009 the patient experienced injection site reaction of soreness, redness and hot to touch.  The patient has sought medical attention at physician's office on 24-SEP-2009 and was advised to apply compress to the area.  Lab technician did not know if the patient had received PNEUMOVAX in the past.  At the time of this report, the patient was not recovered.  This is one of several reports received from the same source.  Additional information has been requested.
This case was reported by a nurse and described the occurrence of expired vaccine used in a patient who received FLUARIX Quadrivalent 2014/2015 season) (batch number FS575, expiry dare 30th June 2014). On 23rd OCTOBER 2014, the patient received FLUARIX Quadrivalent 2014-2015 season. On an unknown date, an unknown time after receiving FLUARIX Quadrivalent 2014-2015 season, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.    Additional information received. 18 patients were involved and investigation still ongoing. Caller did not have patient info. Maladministration caught on 10/23/14.
Information has been received from a nurse practitioner concerning a patient who was vaccinated with a 0.5 ml dose of ZOSTAVAX. It was reported that the patient developed shingles. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
A large (2 inches in diameter), red, lesion around the injection site. Occurred about 7 days after the injection and is continuing as of today (8 days after the injection).  The injection site is swollen ( the top is about 1/3 inch higher than the area around). The lesion feels stiff (similar to when touching a knuckle without much fat underneath), warm, and itchy (similar to a mosquito bite).
12 hours after the Flu Shot, pt complained that he could not move the arm of injection site, felt extreme discomfort (stiffness and pain)around the shoulder, neck and chest.He also had violent headache and nausea. He went to ER after four days of continuous discomfort and malaise, he was given a Vicodin rx for pain and sent home. His discomfort and malaise went away after one week.
Patient was given influenza vaccine and subsequently developed possible Guillain Barre Syndrome (progressive weakness of the extremities, L sided numbness). He had a distant history of GBS at age 18. Now 1 wk out S/P Tx w/IVIG, w/improvement in neurological symptoms but residual hand/leg weakness.
Rash over entire arm where flu shot administered pt had reported prior to administration, she was having difficulty with allergic rxns with food, medications currently but MD could not find out why. No issues with flu shots in past.
A RED RASH DEVELOPED ON RIGHT ARM BUT NOT IN THE AREA WHERE THE INJECTION WAS GIVEN.
P/receiving DTP pt cried for 3 hrs & could not be consoled; started in the evening;
Fever: up to 103.6 for three days Nausea, vomiting, diarrhea for three days Severe headache for two days Muscle aches and extreme fatigue for five days Mild aches and fatigue for additional two days General malaise and feeling yucky for total of six days
nasal and chest congestion, runny nose, fever, loss of taste/smell, and cough.
No additional adverse event; patient was administered VARIVAX via intramuscular route; This spontaneous report was received from a nurse and refers to a patient of unknown age and gender. No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided. On 03-FEB-2020, the patient was vaccinated with varicella virus vaccine live (oka/merck) (VARIVAX) subcutaneous injection, lot # S012036 and expiration date 17-APR-2021 (exact dose was not reported) for prophylaxis, via intramuscular route. The vaccine was reconstituted with sterile diluent (MERCK STERILE DILUENT) injection, intramuscularly, lot # S012824 and expiration date 18-DEC-2021 (strength, dose and frequency were not reported) for prophylaxis. No additional adverse event was reported.
Breakthrough case admission after 4 vaccines Pfizer 1/16/21 lot# EL3249;  Pfizer 2/6/21 lot# EM9810;  Pfizer 10/1/21 lot# EW0183;  Pfizer 6/9/22 lot# FP7BS
She noticed itchiness and a soft bump inside her mouth at 1am.  On July 3 in the morning she noticed that the right side of her face is edematous, she has a papular rash on her lower abdomen, and her arms and legs are itchy (no rash now, but she had 20 bumps right on right lower leg last night which have resolved).  She also had a headache 7/2 in the evening.
Pain in arm restricting movement, severe level lasting for 24 hours; mild pain continuing thereafter. Mild nausea and dizziness/lightheadedness. Mild fatigue.
Red spot in her arm; felt like a be pinch; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Red spot in her arm) and PAIN (felt like a be pinch) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012M20A) for COVID-19 vaccination.     The patient's past medical history included Dental implantation (post in her mouth, two implants).   On 04-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (Red spot in her arm) and PAIN (felt like a be pinch). At the time of the report, ERYTHEMA (Red spot in her arm) and PAIN (felt like a be pinch) outcome was unknown. Not Provided          Concomitant product use was not provided by the reporter.   ?No treatment information was provided. Action taken with mRNA-1273 in response to the event was not applicable.   Reporter did not allow further contact
The patient has swelling, pain and red rash on upper right arm where the shots were administered. It lasted for 48 hours. The patient called the Co Bd of Health the next day and personal physician the day after. Missing vaccine information not available.
On 12/29/20 I developed nasal congestion, sneezing, and a mild cough. Tested positive for Covid 19 on 1230/20.
on the right arm peeled; pain around the injection site; red circle around the injection site; bruise in the area where the injection was given; her right arm was swollen; difficulty sleeping; pain in her right arm; This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a 77-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concomitant products included Herpes zoster (Shingrix).   On 1st September 2020, the patient received the 2nd dose of Shingrix (intramuscular). On 1st September 2020, immediately after receiving Shingrix and an unknown time after receiving Shingrix, the patient experienced injection site pain, injection site erythema and swelling arm. In September 2020, the patient experienced difficulty sleeping, pain in arm and skin peeling. On an unknown date, the patient experienced injection site bruising. In September 2020, the outcome of the injection site pain, injection site erythema, injection site bruising, swelling arm, difficulty sleeping, pain in arm and skin peeling were recovered/resolved.   It was unknown if the reporter considered the injection site pain, injection site erythema, injection site bruising, swelling arm, difficulty sleeping, pain in arm and skin peeling to be related to Shingrix.  Additional details were reported as follows: The patient received the 2nd dose of Shingrix and shortly after, her right arm was swollen, had pain around the injection site, and a red circle around the injection site that was about 4 inches long and 2.5 inches wide and these lasted for 2 weeks and then resolved. The patient reported that she had difficulty sleeping after receiving the second dose because of the pain in her right arm and this lasted 2 weeks and resolved. Patient reported that about 2 weeks after receiving the second dose of Shingrix developed a bruise in the area where the injection was given, and this lasted about 2 weeks and resolved and after that the skin around that same area on the right arm peeled and this had been resolved. The reporter consented to follow up.
Ears have been ringing loudly 24 hours a day; This is a spontaneous report from a contactable consumer, the patient. A 49-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 49-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included bupropion hydrochloride (WELLBUTRIN), ibuprofen (ADVIL) and diphenhydramine hydrochloride (BENADRYL); all for unknown indications from unknown dates and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25Mar2021 at 20:00, the patient's ears had been ringing loudly 24 hours a day. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the event ears have been ringing loudly 24 hours a day was not resolved at the time of the report.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Presented to ER  - somnolent and lethargic.  After morning do dose of inhaler for COPD started to feel congested and short of breath, prompted him to ER.  Did not have fever, chills, HA, rashes or allergic reactions. Started on BIPAP.   No definitive evidence indicating that this was or was not an ADR to vaccine
I went and got my second dose of the Moderna vaccine on 3/9/2022 less then one week and continuing till now my asthma has been getting worse and worse I went to the hospital last month and they said that I was experiencing a severe asthma exacerbation attack but like I never had them every week before they were like every 3-5 years before the vaccine and I had to get 2 rounds of steroid albueterol treatments to clear that up plus they gave me some to use at home which I have had to do every week since due to not being able to breathe like sometime I feel like I literally am dying but I don?t like hospitals so I don?t go unless it gets to that being that I have the steroid asthma treatments at home I just use that here
Shortness of breath and whizzing; Not receiving the 2nd dose; Tiredness; Dizziness; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DYSPNOEA (Shortness of breath and whizzing) in a 78-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011m20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.   The patient's past medical history included No adverse event.  On 28-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Mar-2021, the patient experienced DYSPNOEA (Shortness of breath and whizzing) (seriousness criterion hospitalization). On 07-Apr-2021, the patient experienced DIZZINESS (Dizziness) and FATIGUE (Tiredness ). On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Not receiving the 2nd dose). The patient was hospitalized from 28-Mar-2021 to 06-Apr-2021 due to DYSPNOEA. At the time of the report, DYSPNOEA (Shortness of breath and whizzing), DIZZINESS (Dizziness) and FATIGUE (Tiredness ) had not resolved and PRODUCT DOSE OMISSION ISSUE (Not receiving the 2nd dose) had resolved.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were provided. Patient received a lot of medications at hospital  Company Comment: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
started approx 1:30 AM - shakes (felt like a convulsion) vomiting, diarrhea, shortness of breath, chest tightness - no fever
Syncopal episode 15 hours after administration.  Not otherwise ill.  Brief dizzy spell before he passed out.
Patient was given KINRIX (5th dtap dose and 4th IPV dose in vaccine series) and PRO QUAD (2nd dose of MMR and Varicella in vaccine series). Patient had syncopal episode 5 minutes following MMRV and KINRIX vaccine administration. Patient was sitting in exam room chair and RN noticed facial pallor and extremity weakness. RN performed sternal rubs, and patient was able to voice " I need to go potty". RN transferred patient to exam table while calling for additional RN. RN auscultated breath sounds and HR with stethoscope while additional RN assisted in applying oxygen 2 L via peds mask. Patient was combative while RN attempted to place  pulse ox probe on hand, so one was placed on foot. Once probe was placed, patient's oxygen saturation was 100%. MOC reported that similar episode occurred while patient had hemoglobin testing performed at WIC office. MOC also reports patient did not eat much for lunch today. Patient requested chocolate milk to drink. After a few sips of chocolate milk patient was jumping in office excited to go get a slurpee. RN walked patient and MOC out of office. MOC reported no further concerns or questions.
allergic rxn, eyes burned & watered, tongue & gums burned had asthma attack;ER gave pt pred & DPH & sent home;
10cm x 12cm area with 10 small blisters in a 2x2cm area in middle of area. Area red, swollen, warm to touch.  Follow up: Right thigh site.  Prescribed antibiotics.
She had been anxious prior to receiving her COVID vaccine. Immunizing technician, gave the patient her the covid vaccine. While was waiting 15 minutes after receiving her first COVID vaccine, she started to slump over and pass out. Emergency services were called immediately. Within 20 minutes of the patient passing out, emergency services discharged the patient. Patient was coherent and able to walk around comfortably.
11 mm x 9 mm induration upper left arm. Pt. to use ice and Ibuprofen as treatment.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Other HCP). The reporter is the patient.  A 58-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), on 04Jul2022 as dose number unknown, single (Batch/Lot number: unknown) at the age of 57 years, in right arm for covid-19 immunisation. The patient's relevant medical history included: "Hyper thyroid" (unspecified if ongoing), notes: other medical history: Hyper thyroid; "Allergy" (unspecified if ongoing), notes: other medical history: Allergy. The patient's concomitant medications were not reported. Past drug history included: Ibuprofen, reaction(s): "known allergies: Ibuprofen", notes: known allergies: Ibuprofen. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.; Sender's Comments: Based on the information provided in the narrative, a causal association between the events and the suspect drug cannot be completely excluded.
Chills, headache, fatigue, dizziness, sensitivity to light, fever, night sweats, and muscle soreness.
two of her fingers was in pain and numb; pain in her right arm/ two of her fingers was in pain; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP).  A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 2, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (DOSE 1, SINGLE), for Covid-19 immunization. The following information was reported: HYPOAESTHESIA (non-serious), outcome "unknown", described as "two of her fingers was in pain and numb"; PAIN IN EXTREMITY (non-serious), outcome "unknown", described as "pain in her right arm/ two of her fingers was in pain". Therapeutic measures were taken as a result of hypaesthesia, pain in extremity.  Additional information: The reporter was concerned about his wife (patient) after she got her second dose she was been having so much pain in her right arm and it was not getting better it was getting worse. After the second vaccine with Pfizer the patient started getting some pain like really bad that got as the same day as the vaccine and also two of the patient's fingers was in pain and numb it was not getting better it was getting worse. The patient had been taking Ibuprofen 800 3 times 4 times a day and it was not getting better.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Flu like symptoms, fatigue (lack of energy to do daily activities), disorientation, inability to breath, headaches, sleeping up to 15 hours a day. Lived on over the counter medicine (Musinex), nasal spray, albuterol inhaler, aspirin and alka selter. Started feeling better on February 1st. Scared to take the second round, which is due to be taken on February 16th.